Turnstone Biologics Statistics

Total Valuation

TSBX has a market cap or net worth of $11.59 million. The enterprise value is -$48.60 million.

Market Cap	11.59M
Enterprise Value	-48.60M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

TSBX has 23.13 million shares outstanding. The number of shares has increased by 692.42% in one year.

Shares Outstanding	23.13M
Shares Change (YoY)	+692.42%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	3.83%
Owned by Institutions (%)	34.69%
Float	14.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.19
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.04.

Current Ratio	4.38
Quick Ratio	3.99
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -134.46% and return on invested capital (ROIC) is -85.29%.

Return on Equity (ROE)	-134.46%
Return on Assets (ROA)	-66.10%
Return on Capital (ROIC)	-85.29%
Revenue Per Employee	n/a
Profits Per Employee	-$933,775
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-180,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-74.81%
50-Day Moving Average	0.59
200-Day Moving Average	2.21
Relative Strength Index (RSI)	40.29
Average Volume (20 Days)	138,725

Short Selling Information

The latest short interest is 387,819, so 1.68% of the outstanding shares have been sold short.

Short Interest	387,819
Short Previous Month	497,466
Short % of Shares Out	1.68%
Short % of Float	2.75%
Short Ratio (days to cover)	2.82

Income Statement

Revenue	n/a
Gross Profit	-60.67M
Operating Income	-80.19M
Pretax Income	-75.09M
Net Income	-74.70M
EBITDA	-77.83M
EBIT	-80.19M
Earnings Per Share (EPS)	-$3.45

Full Income Statement

Balance Sheet

The company has $62.40 million in cash and $2.20 million in debt, giving a net cash position of $60.19 million or $2.60 per share.

Cash & Cash Equivalents	62.40M
Total Debt	2.20M
Net Cash	60.19M
Net Cash Per Share	$2.60
Equity (Book Value)	59.74M
Book Value Per Share	2.58
Working Capital	52.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$67.68 million and capital expenditures -$508,000, giving a free cash flow of -$68.18 million.

Operating Cash Flow	-67.68M
Capital Expenditures	-508,000
Free Cash Flow	-68.18M
FCF Per Share	-$2.95

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-692.42%
Shareholder Yield	-692.42%
Earnings Yield	-644.43%
FCF Yield	-588.20%

Analyst Forecast

The average price target for TSBX is $4.75, which is 847.73% higher than the current price. The consensus rating is "Buy".

Price Target	$4.75
Price Target Difference	847.73%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSBX has an Altman Z-Score of -3.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.31
Piotroski F-Score	2